{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T23:24:40Z","timestamp":1720221880025},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.vaccine.2009.07.044","type":"journal-article","created":{"date-parts":[[2009,10,17]],"date-time":"2009-10-17T08:27:11Z","timestamp":1255768031000},"page":"D16-D22","source":"Crossref","is-referenced-by-count":4,"special_numbering":"S4","title":["Vaccines for military use"],"prefix":"10.1016","volume":"27","author":[{"given":"Andrew. W.","family":"Artenstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.07.044_bib1","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1086\/510680","article-title":"An approach to prevention of infectious diseases during military deployments","volume":"44","author":"Murray","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2009.07.044_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.7205\/MILMED.170.4S.3","article-title":"History of U.S. military contributions to the study of vaccines against infectious diseases","volume":"170","author":"Artenstein","year":"2005","journal-title":"Mil Med"},{"key":"10.1016\/j.vaccine.2009.07.044_bib3","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/milmed\/161.9.502","article-title":"Military medicine in operations other than war part II: humanitarian relief missions for naval reserve fleet hospitals","volume":"161","author":"Ryals","year":"1996","journal-title":"Mil Med"},{"key":"10.1016\/j.vaccine.2009.07.044_bib4","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/milmed\/164.8.572","article-title":"The medical department in military operations other than war. Part I. Planning for deployment","volume":"164","author":"Baker","year":"1999","journal-title":"Mil Med"},{"key":"10.1016\/j.vaccine.2009.07.044_bib5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1017\/S1049023X00043314","article-title":"Military assistance in complex emergencies: what have we learned since the Kurdish relief effort?","volume":"16","author":"Sharp","year":"2001","journal-title":"Prehosp Disaster Med"},{"key":"10.1016\/j.vaccine.2009.07.044_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/clinids\/6.1.1","article-title":"Immunization, military medicine","volume":"6","author":"Benenson","year":"1984","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2009.07.044_bib7","first-page":"471","article-title":"Vaccines, historical","volume":"vol. 6","author":"Moloo","year":"2008"},{"key":"10.1016\/j.vaccine.2009.07.044_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/epirev\/mxj003","article-title":"Immunization to protect the US armed forces: heritage, current practice, prospects","volume":"28","author":"Grabenstein","year":"2006","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.vaccine.2009.07.044_bib9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM198703123161106","article-title":"Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease","volume":"316","author":"Redfield","year":"1987","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.vaccine.2009.07.044_bib10","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1586\/14760584.7.8.1225","article-title":"Smallpox vaccines for biodefense: need, feasibility","volume":"7","author":"Artenstein","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2009.07.044_bib11","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/j.vaccine.2005.01.012","article-title":"The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program","volume":"23","author":"Poland","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.07.044_bib12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.0954-6820.1983.tb03692.x","article-title":"Etiology of mild acute infectious myocarditis. Relation to clinical features","volume":"213","author":"Karjalainen","year":"1983","journal-title":"Acta Medica Scandinavica"},{"issue":"4","key":"10.1016\/j.vaccine.2009.07.044_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/rmv.571","article-title":"New generation smallpox vaccines: a review of preclinical, clinical data","volume":"18","author":"Artenstein","year":"2008","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2009.07.044_bib14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.7205\/MILMED.170.4S.66","article-title":"History of U.S. military contributions to the study of respiratory infections","volume":"170","author":"Ottolini","year":"2005","journal-title":"Mil Med"},{"key":"10.1016\/j.vaccine.2009.07.044_bib15","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/infdis\/148.5.775","article-title":"Viral respiratory disease at Lowry Air Force Base in Denver, 1952\u20131982","volume":"148","author":"Meiklejohn","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.07.044_bib16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1056\/NEJM196007282630408","article-title":"Studies on an attenuated measles virus vaccine. VIII. General summary, evaluation of results of vaccine","volume":"263","author":"Katz","year":"1960","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2009.07.044_bib17","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJM196802012780501","article-title":"Live attenuated mumps-virus vaccine","volume":"278","author":"Hilleman","year":"1968","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2009.07.044_bib18","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/jama.215.4.613","article-title":"Rubella vaccination: a review of practical experience","volume":"215","author":"Meyer","year":"1971","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2009.07.044_bib19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3181\/00379727-111-27750","article-title":"Recovery of rubella virus from army recruits","volume":"111","author":"Parkman","year":"1962","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.vaccine.2009.07.044_bib20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0264-410X(93)90234-O","article-title":"Susceptibility in USAF recruits to vaccine-preventable diseases","volume":"11","author":"Clardy","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.07.044_bib21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/infdis\/170.1.216","article-title":"Evidence for a recent decrease in measles susceptibility among young American adults","volume":"170","author":"Smoak","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.07.044_bib22","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/milmed\/163.9.631","article-title":"A cost-benefit analysis of a routine varicella vaccination program for United States Air Force Academy cadets","volume":"163","author":"Burnham","year":"1998","journal-title":"Mil Med"},{"key":"10.1016\/j.vaccine.2009.07.044_bib23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.7205\/MILMED.170.4S.71","article-title":"History of U.S. military contributions to the study of viral hepatitis","volume":"170","author":"Dooley","year":"2005","journal-title":"Mil Med"},{"issue":"15","key":"10.1016\/j.vaccine.2009.07.044_bib24","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1001\/jama.1945.02860320004002","article-title":"The use of human immune serum globulin (gamma-globulin) in infectious (epidemic) hepatitis in the Mediterranean theater of operations. I. Studies on prophylaxis in two epidemics of infectious hepatitis","volume":"128","author":"Gellis","year":"1945","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2009.07.044_bib25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jama.1945.02860030016004","article-title":"The prevention, attenuation of infectious hepatitis by gamma-globulin: preliminary note","volume":"127","author":"Stokes","year":"1945","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.vaccine.2009.07.044_bib26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM199208133270702","article-title":"A controlled trial of formalin-inactivated hepatitis A vaccine in healthy children","volume":"327","author":"Werzberger","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2009.07.044_bib27","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1001\/jama.271.17.1328","article-title":"Protection against hepatitis A by an inactivated vaccine","volume":"271","author":"Innis","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2009.07.044_bib28","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/hep.1840180407","article-title":"Mortality follow-up of the 1942 epidemic of hepatitis B in the U.S. Army","volume":"18","author":"Norman","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.vaccine.2009.07.044_bib29","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3201\/eid0703.017320","article-title":"Outbreak of influenza in highly vaccinated crew of U.S. Navy ship","volume":"7","author":"Earhart","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2009.07.044_bib30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3201\/eid1209.05-0979","article-title":"1918 Influenza: the mother of all pandemics","volume":"12","author":"Taubenberger","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2009.07.044_bib31","series-title":"Textbooks of military medicine","first-page":"1","article-title":"The Armed Forces Epidemiological Board: its first fifty years 1940\u20131990","author":"Woodward","year":"1990"},{"key":"10.1016\/j.vaccine.2009.07.044_bib32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3201\/eid0503.990308","article-title":"Respiratory diseases among U.S. military personnel: countering emerging threats","volume":"5","author":"Gray","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2009.07.044_bib33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3181\/00379727-85-20825","article-title":"Recovery of new agent from patients with acute respiratory illness","volume":"85","author":"Hilleman","year":"1954","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.vaccine.2009.07.044_bib34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/oxfordjournals.aje.a121499","article-title":"Acute respiratory disease in military trainees: the adenovirus surveillance program, 1966\u20131971","volume":"97","author":"Dudding","year":"1973","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2009.07.044_bib35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-065X.1999.tb01325.x","article-title":"Personal historical chronicle of six decades of basic, applied research in virology, immunology, vaccinology","volume":"170","author":"Hilleman","year":"1999","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2009.07.044_bib36","series-title":"Vaccines","first-page":"863","article-title":"Adenovirus vaccine","author":"Gaydos","year":"2004"},{"key":"10.1016\/j.vaccine.2009.07.044_bib37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/oxfordjournals.aje.a120805","article-title":"Live, inactivated adenovirus vaccines for the prevention of acute respiratory illness in naval recruits","volume":"87","author":"Pierce","year":"1968","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.044_bib38","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/infdis\/124.2.148","article-title":"Immunization with live types 7, 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, potency of adenovirus type 7 vaccine in humans","volume":"124","author":"Top","year":"1971","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.07.044_bib39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/infdis\/124.2.155","article-title":"Immunization with live types 7, 4 adenovirus vaccines. II. Antibody response, protective effect against acute respiratory disease due to adenovirus type 7","volume":"124","author":"Top","year":"1971","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.07.044_bib40","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/infdis\/128.6.745","article-title":"Adenovirus vaccines in military recruit populations: a cost-benefit analysis","volume":"128","author":"Collis","year":"1973","journal-title":"J Infect Dis"},{"issue":"23","key":"10.1016\/j.vaccine.2009.07.044_bib41","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1016\/j.vaccine.2008.03.037","article-title":"A double-blind placebo-controlled study of the safety, immunogenicity of live, oral type 4, type 7 adenovirus vaccines in adults","volume":"26","author":"Lyons","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.07.044_bib42","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/milmed\/135.9.735","article-title":"Current status of prophylaxis of meningococcal disease","volume":"135","author":"Artenstein","year":"1970","journal-title":"Mil Med"},{"key":"10.1016\/j.vaccine.2009.07.044_bib43","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2009.07.044_bib44","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1084\/jem.129.6.1327","article-title":"Human immunity to the meningococcus. II. The development of natural immunity","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2009.07.044_bib45","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1084\/jem.129.6.1349","article-title":"Human immunity to the meningococcus. III. Preparation, immunochemical properties of the group A, group B, group C meningococcal polysaccharides","volume":"129","author":"Gotschlich","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2009.07.044_bib46","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.129.6.1367","article-title":"Human immunity to the meningococcus. IV. Immunogenicity of group A, group C meningococcal polysaccharides in human volunteers","volume":"129","author":"Gotschlich","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2009.07.044_bib47","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1084\/jem.129.6.1385","article-title":"Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state","volume":"129","author":"Gotschlich","year":"1969","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.vaccine.2009.07.044_bib48","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM197002192820803","article-title":"Prevention of meningococcal disease by group C polysaccharide vaccine","volume":"282","author":"Artenstein","year":"1970","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2009.07.044_bib49","first-page":"279","article-title":"Meningococcal infections 2. Field trial of group C meningococcal polysaccharide vaccine in 1969\u20131970","volume":"45","author":"Gold","year":"1971","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2009.07.044_bib50","series-title":"Vaccines","first-page":"959","article-title":"Meningococcal vaccines","author":"Granoff","year":"2004"},{"issue":"9251","key":"10.1016\/j.vaccine.2009.07.044_bib51","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0140-6736(00)03594-7","article-title":"Efficacy of meningococcal serogroup C conjugate vaccine in teenagers, toddlers in England","volume":"357","author":"Ramsay","year":"2001","journal-title":"Lancet"},{"issue":"32","key":"10.1016\/j.vaccine.2009.07.044_bib52","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1016\/j.vaccine.2005.03.045","article-title":"Impact, effectiveness of meningococcal C conjugate vaccine following its introduction in Spain","volume":"23","author":"Larrauri","year":"2005","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.07.044_bib53","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.inf.0000195594.41449.c6","article-title":"Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands","volume":"25","author":"de Greef","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2009.07.044_bib54","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1084\/jem.65.6.787","article-title":"The use of yellow fever virus modified by in vitro cultivation for human immunization","volume":"65","author":"Theiler","year":"1937","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2009.07.044_bib55","doi-asserted-by":"crossref","first-page":"92","DOI":"10.7205\/MILMED.170.4S.92","article-title":"History of U.S. military contributions to the study of viral encephalitis","volume":"170","author":"Hoke","year":"2005","journal-title":"Mil Med"},{"issue":"10","key":"10.1016\/j.vaccine.2009.07.044_bib56","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1056\/NEJM198809083191004","article-title":"Protection against Japanese encephalitis by inactivated vaccines","volume":"19","author":"Hoke","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2009.07.044_bib57","series-title":"Vaccines","first-page":"1039","article-title":"Tick-borne encephalitis virus vaccine","author":"Barrett","year":"2004"},{"issue":"6","key":"10.1016\/j.vaccine.2009.07.044_bib58","doi-asserted-by":"crossref","first-page":"874","DOI":"10.4269\/ajtmh.1999.61.874","article-title":"An accelerated schedule for tick-borne encephalitis vaccine: the American military experience in Bosnia","volume":"61","author":"Craig","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2009.07.044_bib59","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1086\/510859","article-title":"Anthrax: from antiquity to answers","volume":"195","author":"Artenstein","year":"2007","journal-title":"J Infect Dis"},{"issue":"17","key":"10.1016\/j.vaccine.2009.07.044_bib60","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1001\/jama.287.17.2236","article-title":"Anthrax as a biological weapon, 2002: updated recommendations for management","volume":"287","author":"Inglesby","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2009.07.044_bib61","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/milmed\/157.8.404","article-title":"Investigational drugs, vaccines fielded in support of Operation Desert Storm","volume":"157","author":"Berezuk","year":"1992","journal-title":"Mil Med"},{"issue":"12","key":"10.1016\/j.vaccine.2009.07.044_bib62","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/pds.936","article-title":"Safety of anthrax vaccine: an expanded review, evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)","volume":"13","author":"Sever","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2009.07.044_bib63","series-title":"Vaccines","first-page":"989","article-title":"Miscellaneous limited-use vaccines","author":"Pittman","year":"2004"},{"key":"10.1016\/j.vaccine.2009.07.044_bib64","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7205\/MILMED.170.4S.77","article-title":"History of U.S. military contributions to the study of viral hemorrhagic fevers","volume":"170","author":"Thomas","year":"2005","journal-title":"Mil Med"},{"issue":"18","key":"10.1016\/j.vaccine.2009.07.044_bib65","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","article-title":"Hemorrhagic fever viruses as biological weapons: medical, public health management","volume":"287","author":"Borio","year":"2002","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.vaccine.2009.07.044_bib66","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1086\/514211","article-title":"Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group","volume":"177","author":"Maiztegui","year":"1998","journal-title":"J Infect Dis"},{"issue":"4 Suppl.","key":"10.1016\/j.vaccine.2009.07.044_bib67","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7205\/MILMED.170.4S.12","article-title":"History of U.S. military contributions to the study of malaria","volume":"170","author":"Ockenhouse","year":"2005","journal-title":"Mil Med"},{"key":"10.1016\/j.vaccine.2009.07.044_bib68","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(95)92900-2","article-title":"Multiple introductions of HIV-1 subtype E into the Western Hemisphere","volume":"346","author":"Artenstein","year":"1995","journal-title":"Lancet"},{"issue":"8984","key":"10.1016\/j.vaccine.2009.07.044_bib69","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0140-6736(95)92901-0","article-title":"Detection of diverse HIV-1 subtypes in the United States","volume":"346","author":"Brodine","year":"1995","journal-title":"Lancet"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09010561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09010561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T06:44:42Z","timestamp":1558593882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09010561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":69,"alternative-id":["S0264410X09010561"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.07.044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}